Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021

Direct-acting antiviral (DAA) treatment discontinuation may negatively impact HCV elimination efforts. In Australia, DAA therapy is pharmacy dispensed, generally in 4-week amounts, with the approved duration (8–24 wk) and volume dispensed reported in pharmaceutical administrative data. This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Carson, Joanne, Barbieri, Sebastiano, Matthews, Gail V., Dore, Gregory J., Hajarizadeh, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069828/
https://www.ncbi.nlm.nih.gov/pubmed/36995991
http://dx.doi.org/10.1097/HC9.0000000000000125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069828/
https://www.ncbi.nlm.nih.gov/pubmed/36995991
http://dx.doi.org/10.1097/HC9.0000000000000125

Ejemplares similares